The United Laboratories International Holdings Limited

SHSC:3933 Stock Report

Market Cap: HK$17.9b

United Laboratories International Holdings Future Growth

Future criteria checks 1/6

United Laboratories International Holdings is forecast to grow earnings and revenue by 3.9% and 6.1% per annum respectively. EPS is expected to grow by 4% per annum. Return on equity is forecast to be 19.5% in 3 years.

Key information

3.9%

Earnings growth rate

4.0%

EPS growth rate

Pharmaceuticals earnings growth11.1%
Revenue growth rate6.1%
Future return on equity19.5%
Analyst coverage

Good

Last updated31 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:3933 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202616,3933,206N/A3,7567
12/31/202515,3823,015N/A3,5458
12/31/202414,6642,928N/A3,5458
6/30/202414,0092,9081,4203,088N/A
3/31/202413,8752,8051,2672,763N/A
12/31/202313,7402,7011,1142,439N/A
9/30/202313,3992,4691,3762,504N/A
6/30/202313,0592,2361,6372,568N/A
3/31/202312,1971,9091,4442,300N/A
12/31/202211,3341,5811,2512,031N/A
9/30/202210,7501,2881,0661,683N/A
6/30/202210,1669958821,336N/A
3/31/20229,9359919681,439N/A
12/31/20219,7039881,0551,543N/A
9/30/20219,4451,0561,0471,647N/A
6/30/20219,1871,1231,0391,752N/A
3/31/20218,9809131,0351,660N/A
12/31/20208,7727031,0301,568N/A
9/30/20208,6906261,1281,625N/A
6/30/20208,6075491,2261,683N/A
3/31/20208,5005951,2931,742N/A
12/31/20198,3936421,3611,801N/A
9/30/20198,1007651,1471,618N/A
6/30/20197,8088889321,436N/A
3/31/20197,6597858061,324N/A
12/31/20187,5116836811,213N/A
9/30/20187,3953736401,104N/A
6/30/20187,28064599995N/A
3/31/20187,05373N/A883N/A
12/31/20176,82782N/A770N/A
9/30/20176,640-34N/A957N/A
6/30/20176,454-150N/A1,144N/A
3/31/20176,266-211N/A1,109N/A
12/31/20166,078-272N/A1,074N/A
9/30/20166,083-216N/A976N/A
6/30/20166,076-159N/A875N/A
3/31/20166,195-32N/A1,182N/A
12/31/20156,44692N/A1,516N/A
9/30/20156,597148N/A1,522N/A
6/30/20156,711201N/A1,521N/A
3/31/20156,565373N/A1,460N/A
12/31/20146,422545N/A1,400N/A
9/30/20146,179552N/A1,436N/A
6/30/20146,101574N/A1,511N/A
3/31/20146,112306N/A1,347N/A
12/31/20135,97238N/A1,155N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 3933's forecast earnings growth (3.9% per year) is above the savings rate (2.3%).

Earnings vs Market: 3933's earnings (3.9% per year) are forecast to grow slower than the Hong Kong market (11.7% per year).

High Growth Earnings: 3933's earnings are forecast to grow, but not significantly.

Revenue vs Market: 3933's revenue (6.1% per year) is forecast to grow slower than the Hong Kong market (7.8% per year).

High Growth Revenue: 3933's revenue (6.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 3933's Return on Equity is forecast to be low in 3 years time (19.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y